UBS Maintains Neutral on Bath & Body Works, Lowers Price Target to $17
Bath & Body Works, Inc.
Bath & Body Works, Inc. BBWI | 0.00 |
UBS analyst Jay Sole maintains Bath & Body Works (NYSE:
BBWI) with a Neutral and lowers the price target from $19 to $17.
